Juvenescence Ltd 4
4 · AgeX Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Juvenescence Ltd
10% Owner
Transactions
- Award
Warrant to Purchase Common Stock
2022-12-19+847,457→ 847,457 totalExercise: $0.59Exp: 2025-12-14→ Common Stock (847,457 underlying)
Footnotes (2)
- [F1]Warrants issued in connection with the draw of loan funds under a Secured Convertible Promissory Note between the issuer and the reporting person.
- [F2]The warrants are exercisable for shares of the issuer's common stock upon issuance.